NAACCR Item #3896: NCCN International Prognostic Index (IPI)
|Item #||Length||Source of Standard||Year Implemented||Version Implemented||Year Retired||Version Retired|
NAACCR XML: Tumor.nccnInternationalPrognosticIndex
The NCCN International Prognostic Index (IPI) (previously only "IPI") is used to define risk groups for specific lymphomas using a 0-8 score range, based on age, stage, number of extranodal sites of involvement, patient's performance status and pretreatment LDH level.
NCCN International Prognostic Index (IPI) is a Registry Data Collection Variable in AJCC. It was previously collected for Lymphomas, SSF# 3.
|X1||Stated as low risk (0-1 point)|
|X2||Stated as low intermediate risk (2-3 points)|
|X3||Stated as intermediate risk (4-5 points)|
|X4||Stated as high risk (6-8 points)|
|X8||Not applicable: Information not collected for this case (If this item is required by your standard setter, use of code X8 will result in an edit error.)|
|X9||Not documented in medical record NCCN International Prognostic Index (IPI) not assessed or unknown if assessed|
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.